Published Online: Saturday, April 1, 2006

Although the generics industry promotes its products as therapeutically identical to higher-priced brand name drugs, newly published research now suggests that patient adherence to a therapeutic regimen is higher for patients on generics rather than branded drugs. The study, published in the February 13, 2006, issue of the journal Archives of Internal Medicine, concluded that patients given the generic version of a drug were found to adhere to their treatments better than those prescribed the brand name versions. "After controlling for patient sociodemographic characteristics and drug class, [the proportion of days covered] was 12.6% greater for patients initiated on generic medications," the researchers concluded.

Latest Articles
Police and a CVS pharmacy are on the lookout for a man who stole several boxes of diabetic test strips.
The FDA has approved Merck’s supplemental new drug application for single-dose fosaprepitant dimeglumine for injection.
Diabetes is not a fun condition.
OTC medications can have serious side effects in children if they are not carefully administered.
Latest Issues